Find your path to Olivier
124 people in our graph share verified history with Olivier — schools, employers, funds. One of them is your warm intro.
Mike FitzgeraldunlockedOlivier: together at Roche (2001–2003)
×9Olivier: together at Roche
×2Olivier: together at IMD
About
Biotech leader with expertise in rare metabolic diseases and orphan drugs. Co-founder and former CEO of Azafaros, with senior roles at Actelion and Idorsia. Holds a Doctorate in Biology and Genetics from the University Paris VII.
Experience
- BiomedVCVenture Partnercurrent2023 — present
- Scenic BiotechSenior Advisor Rare Diseasescurrent2021 — presentAmsterdam, NL
- Theralto GmbHFounder, Executive Directorcurrent2018 — presentBasel, Switzwerland
- AZAFAROS B.V.Chief Executive Officer2018 — 2021Leiden, The Netherlands
- Idorsia Pharmaceuticals LtdSenior Director, Rare Disease Therapeutic area2017 — 2018Allschwil/Basel, Switzerland
- Actelion Pharmaceuticals Ltd.Senior Director, Clinical Science Program Head2016 — 2017Allschwil, Switzerland
- Actelion Pharmaceuticals Ltd.Senior Director, Clinical Project Team Leader and Scientific Expert2015 — 2016Allschwil, Switzerland
- Actelion Pharmaceuticals Ltd.Senior Director, Global Life Cycle Leader2003 — 2015Allschwil, Switzeralnd
- RocheScientific Expert, Project Leader, and Peer-Review Committee member1989 — 2003Basel, Basel, Switzerland
- Merck & Co., Inc.Research Scientist1988 — 1989Rahway, NJ, USA
- University of Wisconsin–Madison Department of BiochemistryResearch Associate1985 — 1988Madison, WI, USA
- INSERM, Hôpital de la Pitié-Salpêtrière, Department of NeurochemistryChargé de Recherche1982 — 1985Greater Paris Metropolitan Region
- Mount Sinai School of Medicine, Department of Human GeneticsPost-Doctoral Fellow:1981New York, NY, USA
- Hadassah Medical School, Hebrew UniversityPost-Doctoral Fellow:1980Jerusalem, Israel
Skills & more
Clinical Trials9Cardiology2Pharmaceutical Sales3Clinical Development9Project Management5GCP5Oncology3Strategic Planning3Pharmaceutical Industry11
From Olivier's professional profile.
Colleagues at BioMedPartners
Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Dr. Aristotelis Nastos
Managing Partner at BioMedPartners
Dr. Claudia Ulbrich
Venture Partner at BioMedPartners
Dr. David Urech
Venture Partner at BioMedPartners
Dr. Marianna Feretzaki
Senior Associate at BioMedPartners
Dr. Markus Hosang
Managing Partner at BioMedPartners
Frequently asked questions
- Who is Olivier Morand?
- Biotech leader with expertise in rare metabolic diseases and orphan drugs. Co-founder and former CEO of Azafaros, with senior roles at Actelion and Idorsia. Holds a Doctorate in Biology and Genetics from the University Paris VII.
- Where does Olivier Morand work?
- Olivier Morand is Venture Partner at BioMedPartners.
- Where did Olivier Morand go to school?
- Olivier Morand studied at IMD (Program for Executive Development); University Paris VII (Doctorat d'Etat ès Sciences, Biology and Genetics); University Paris VI, France (Doctorat de 3ème Cycle, Nutrition).
Same school
Also attended IMD261
Karthik ChakkarapaniInvestor at Foundation CapitalKulpreet SinghOperating Advisor at OpenOceanMusaad AlkadiSr. Principal at Graphene VenturesGrant AllenFounding GP, Schneider Electric Ventures at Giant Ventures Global LlpFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgMichael ZehnderHead of Digital Technology & Intelligence at Emerald Technology Ventures Ag
+ 255 more
Shared employers
Also worked at Scenic Biotech9
Stephan ChristgauFounding Partner at EIR VenturesAlexandra (Sandra) GlucksmannAdvisory Partner at Adjuvant CapitalMichael WackerManaging Partner at BioMedPartnersEdward van WezelManaging Partner at BioGeneration VenturesThijs Cohen TervaertPartner at InkefAndrew McLeanManaging Partner at Tin Alley Ventures
+ 3 more
